Yes. And a Zero Is Still a Strong Result.
Both of those are true, and holding them together is the point of this article.
A calcium score of zero is among the strongest low-risk findings in preventive cardiology. Across 13 pooled studies, among the nearly 26,000 people without symptoms who scored zero, 0.56 percent had a cardiovascular event over about four years. In the MESA population study, ten-year event rates for people with a zero ran from 1.3 to 5.6 percent depending on age, sex, and race.
Low is not nothing. Whether you are still at risk of developing heart disease with a zero calcium score depends a great deal on who you are, and that is what the rest of this article is about.
Important: If you develop new, worsening, or persistent chest discomfort, shortness of breath, nausea, or pain in your arm, jaw, neck, or back, call 911. A past calcium score is not part of that decision. More on why below.
What a Zero Rules Out, and What It Never Saw
A calcium scan detects calcified plaque. That is its entire job, and it does it well. What it cannot see is plaque that has not hardened yet, which is the kind more associated with rupture.
The numbers on soft plaque with a zero calcium score are specific.
- Without symptoms, about 1 in 10 has noncalcified plaque on CT angiography, and about 1 in 90 has noncalcified plaque causing a significant narrowing.
- With symptoms, about 1 in 6 has plaque of some kind. In one series of symptomatic patients at intermediate or high risk, about 1 in 3 had noncalcified plaque.
- A zero makes significant narrowing unlikely without ruling it out. In the CONFIRM registry of more than 10,000 symptomatic patients, 3.5 percent of those with a zero had a narrowing of 50 percent or more, and 1.4 percent had one of 70 percent or more.
That last group matters more than its size suggests. Among people with a zero, those who did have a significant narrowing carried more than five times the rate of events of those who did not.
So a zero means no calcium was found. It does not mean no plaque, no narrowing, or no risk.
Who Should Be Careful With a Zero
This is the part that general advice tends to skip. A zero does not mean the same thing in every person.
If you smoke
A zero calcium score and smoking is the combination most often misread, and the evidence is stark. In a study of more than 44,000 people, among the roughly 20,000 who had a zero score, smokers carried about three and a half times the risk of death of nonsmokers with the same zero score, after accounting for other risk factors. The authors’ summary is the line worth remembering: smokers with no calcium had mortality similar to nonsmokers who did have mild to moderate calcified plaque.
Smoking does not speed up calcification much. It raises risk at every calcium level, including zero. Those are different things, and the second one is what matters here.
This also changes the treatment conversation. The 2026 cholesterol guideline permits deferring a statin on a zero score, but lists current cigarette smoking among the higher-risk conditions where deferral is not appropriate. A zero is not a reason to defer if you smoke.
If you have diabetes
A zero does not last as long. In the MESA analysis of how quickly people develop calcium, diabetes shortened the useful life of a zero by roughly a third to 40 percent: 4.3 years against 6.9 in women, and 3.1 against 4.8 in men.
Calcium scoring still works in diabetes. The floor is simply higher.
Diabetes over age 40 is also on the guideline’s list of conditions where deferring a statin on a zero is not appropriate, along with current smoking, a strong family history of premature heart disease, and very high cholesterol. A zero is not a reason to defer if you have diabetes.
If you have symptoms, at any age
This is the hardest limit on the test, and it is measured rather than assumed. In nearly 24,000 symptomatic patients, two figures move in opposite directions with age.
| Age | Chance a symptomatic person with a zero has a significant narrowing | Share of all significant narrowings that a zero missed |
|---|---|---|
| Under 40 | 3 percent | 58 percent |
| 40 to 49 | 5 percent | 34 percent |
| 50 to 59 | 6 percent | 18 percent |
| 60 to 69 | 6 percent | 9 percent |
| 70 and over | 8 percent | 5 percent |
The right column first. Calcification takes years, so in a younger person a zero may mean not yet, and the plaque is more likely to be entirely noncalcified. Over half the significant narrowings in symptomatic under-40s sat behind a zero.
The left column runs the other way. If you have symptoms, your own chance of a narrowing does not fall with age. It is highest in the oldest group. So a zero at 70 misses a smaller share of the disease that is out there while telling that person no more about themselves. Neither age gets to treat a zero as an all-clear while symptoms are present.
In young adults without symptoms, a zero is genuinely reassuring. The concern is about using one to rule out disease in someone who has symptoms.
If your cholesterol is very high, or you have established heart disease
A zero does not change the decision here. Guidance indicates statin therapy on cholesterol alone when LDL is 190 mg/dL or above, or where familial hypercholesterolemia is present, and for anyone with established cardiovascular disease. A calcium score adds nothing to those decisions. If this is your situation, our article on high cholesterol with a zero calcium score goes further.
Where the picture is more mixed than you would expect
Two of these are counterintuitive, and the honest answer is more careful than the instinct.
Lipoprotein(a). You would expect a high Lp(a) to make a zero less reassuring. The MESA analysis that tested it did not find that: risk came out at 1.31 against people with normal Lp(a) and a zero, with a margin of error that included no difference at all. That is not proof the two are equivalent, and the subgroup was small. Lp(a) remains a lifelong inherited exposure that guidelines treat as a reason for more intensive cholesterol lowering. A zero appears to pull risk down even when Lp(a) is high, but not clearly enough to act on by itself.
Family history. A strong family history of premature heart disease is also on the guideline’s list of exceptions to deferring a statin on a zero. Yet in the MESA data it shortened the useful life of a zero by only about 10 percent, and not significantly. That recommendation reflects how high the underlying risk is, not evidence that the scan performs worse.
A note on women
A zero is not less reliable in women. Women actually develop calcium more slowly than men, so their zero lasts longer. The genuine concern for women is a different one: they more often have chest pain from problems a calcium scan was never designed to find, including small-vessel and non-obstructive disease. That is a reason to take symptoms seriously, not a reason to distrust the score.
If You Develop Symptoms, the Zero Stops Counting
This deserves its own section, because it is the most consequential thing in the article.
A zero calcium score with chest pain is evaluated on the chest pain, not on the score. A previous zero is not a reason to wait, not a reason to decline evaluation, and not a point to raise as evidence that the symptom is probably nothing.
Two facts behind that:
- Even a current zero in someone with symptoms leaves a 3 to 8 percent chance of a significant narrowing, depending on age.
- A score from two years ago is already out of date for about one person in nine, because 11.4 percent develop calcium within two years.
Discomfort that comes and goes still counts. So does discomfort that has not changed but will not settle. If you are not sure, call 911 anyway.
What It Does Not Mean
- It does not mean you should stop a medication. The guidance permits deferring a statin in one narrow risk band, which is a different act from stopping a prescription you already have for a reason.
- It does not mean the test failed, even though a large share of events happens in people with a zero. In that 24,000-patient symptomatic group, 31 percent of all deaths and heart attacks occurred in people who scored zero. That figure is large because the zero group was large, more than half the cohort, not because individual risk was high. The per-person rate stayed under one percent a year. Share of events and personal risk are different quantities.
- It does not mean your blood pressure matters less. A calcium score does not measure blood pressure at all.
- It does not mean the result is permanent. A zero has a shelf life.
- It does not mean the number is meaningless. A zero is among the most useful negative results in cardiology, and it genuinely does reclassify people downward.
The goal is to understand your complete cardiovascular picture.
Questions to Discuss With Your Physician
- Given my age and my other risk factors, how much weight should my zero carry?
- Am I in one of the groups where a zero does not change the treatment decision?
- When should this be repeated, and what would make us do it sooner?
- What is my blood pressure and cholesterol plan, independent of the scan?
- Has my Lp(a) been measured at least once?
How Long Your Zero Lasts, and the Pattern Nobody Warns You About
So how long does a zero calcium score last? Years, not decades. In the MESA analysis, among people who started at zero, 11.4 percent had developed calcium within two years, 20 percent within four, and 52 to 53 percent by ten. The useful re-scan window worked out at three to seven years, shortest in people with diabetes and those at high baseline risk. A separate long-term study found the much-quoted 15-year reassurance held only at low and intermediate risk. In high-risk patients it was five to six years.
Now the part worth knowing. In a randomized trial of calcium scanning, people who saw calcium improved their risk factors over the next four years. People who got a zero did not. Their risk scores drifted upward while the other group improved. They did not stop their medications and were no worse off than people never scanned, but they lost the benefit the scan gave everyone else.
That is not harm. It is a benefit the zero group did not get, and it is quiet rather than dramatic, which is exactly why a follow-up plan matters. These markers help us identify where we may be able to reduce risk.
What holds risk down is the same list it always was: blood pressure measured at home rather than once a year, cholesterol treated to a target, blood sugar, not smoking, and activity. Medication may be one part of the strategy. Lifestyle and metabolic optimization remain important regardless.
One more thing, plainly. No randomized trial has shown it is safe to withhold a statin because of a zero score. The one trial that tested calcium-guided treatment in people with a family history excluded everyone who scored zero. The deferral option rests on observational data, which is a reasonable basis for a conversation rather than a settled fact.
Where CoCardio® Fits
Detect Early. Protect Fully. Connect Deeply.
A zero is a good result and a narrow one. It answers one question about calcified plaque at one moment, and leaves your blood pressure, cholesterol, metabolic health, and Lp(a) exactly where they were.
The Root Cause Consultation reviews your health history, your current medical care, your prior testing, and your family history. It is an educational conversation rather than a clinical evaluation, and it is a good place to arrive with questions about what your zero does and does not cover, and when it is worth looking again.
Positioning, stated plainly. Medication is one tool. The bigger opportunity is understanding your actual cardiovascular risk and building a comprehensive prevention plan around it. This article is not anti-statin and not anti-medication.
Boundary. CoCardio® never advises starting, stopping, or changing prescribed medication. Diagnosis and clinical interpretation belong with your own physician.
For your privacy, please share results only through our secure booking and intake process, and do not share personal health information in public comments or unsecured messages.
Frequently Asked Questions
Can you have heart disease with a zero calcium score?
Yes. About one in ten people without symptoms and a zero have plaque that has not calcified, and among symptomatic people with a zero, roughly 3.5 percent have a narrowing of 50 percent or more. A zero makes disease much less likely. It does not exclude it.
How long does a zero calcium score last?
It depends on your risk. Across the MESA data the useful window was three to seven years, shortest with diabetes and at high baseline risk. Within two years, 11.4 percent of people who started at zero had developed some calcium.
Does a zero calcium score mean my risk is zero?
No. Rates are low, about 0.56 percent over four years without symptoms and 1.3 to 5.6 percent over ten years in MESA. Those are among the lowest measurable in prevention, and they are not zero.
Should I worry about chest pain if my score was zero?
Yes, and your score should not enter into it. Even a current zero in a symptomatic person leaves a 3 to 8 percent chance of a significant narrowing, and among symptomatic under-40s who had one, 58 percent had scored zero.
Is a zero less reliable in women?
No. Women develop coronary calcium more slowly, so a zero lasts longer in women, and it has not been shown to predict less well. The separate and real issue is that women more often have chest pain from problems a calcium scan does not measure.
Sources and Disclaimer
Sources. Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC: Cardiovascular Imaging, 2009, pooled analysis of 13 asymptomatic and 7 symptomatic studies. Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease events, the Multi-Ethnic Study of Atherosclerosis, European Heart Journal, 2018. Valenti V, Ó Hartaigh B, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium, JACC: Cardiovascular Imaging, 2015, 9,715 individuals. Mortensen MB, Gaur S, Frimmer A, et al. Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients, JAMA Cardiology, 2021, 23,759 patients over 4.3 years. McEvoy JW, Blaha MJ, Rivera JJ, et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification, JACC: Cardiovascular Imaging, 2012, 44,042 patients. Dzaye O, Dardari ZA, Cainzos-Achirica M, et al. Warranty period of a calcium score of zero, comprehensive analysis from the Multi-Ethnic Study of Atherosclerosis, JACC: Cardiovascular Imaging, 2021;14:990-1002. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography, the CONFIRM registry, Journal of the American College of Cardiology, 2011;58:2533-2540. Sama C, Abdelhaleem A, Velu D, et al. Non-calcified plaque in asymptomatic patients with zero coronary artery calcium score, a systematic review and meta-analysis, Journal of Cardiovascular Computed Tomography, 2024;18:43-49, 37,808 patients. Alqarqaz M, Zaidan M, Al-Mallah MH. Prevalence and predictors of atherosclerosis in symptomatic patients with zero calcium score, Academic Radiology, 2011. Agha AM, Pacor J, Grandhi GR, et al. The prognostic value of CAC zero among individuals presenting with chest pain, a meta-analysis, JACC: Cardiovascular Imaging, 2022. Mehta A, Vasquez N, Ayers CR, et al. Independent association of lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk, Journal of the American College of Cardiology, 2022;79:757-768. Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing, the EISNER randomized trial, Journal of the American College of Cardiology, 2011. Blumenthal RS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia, Circulation, published online March 13, 2026, doi:10.1161/CIR.0000000000001423. Coronary Artery Calcium Score Use to Guide Management of Hereditary Coronary Artery Disease, the CAUGHT-CAD randomized trial, JAMA, 2025.
This article is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Individual circumstances vary, and decisions regarding cardiovascular care should be made with appropriate healthcare professionals.
CoCardio® services are designed to complement, not replace, emergency care, a cardiologist, primary care physician, cardiac rehabilitation program, prescribed medication, diagnostic testing, or medically recommended procedures.
If you have new, severe, or worsening symptoms, seek appropriate medical attention rather than relying on information provided in this article.




